BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25459148)

  • 1. A role for tissue plasminogen activator in thrombotic thrombocytopenic purpura.
    Hoirisch-Clapauch S; Nardi AE
    Med Hypotheses; 2014 Dec; 83(6):747-50. PubMed ID: 25459148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
    Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
    Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpura.
    Feys HB; Vandeputte N; Palla R; Peyvandi F; Peerlinck K; Deckmyn H; Lijnen HR; Vanhoorelbeke K
    J Thromb Haemost; 2010 Sep; 8(9):2053-62. PubMed ID: 20553378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    George JN
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):627-32. PubMed ID: 16167049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic thrombocytopenic purpura associated with von Willebrand factor-cleaving protease (ADAMTS13) deficiency in children.
    Loirat C; Veyradier A; Girma JP; Ribba AS; Meyer D
    Semin Thromb Hemost; 2006 Mar; 32(2):90-7. PubMed ID: 16575683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura: a moving target.
    Sadler JE
    Hematology Am Soc Hematol Educ Program; 2006; ():415-20. PubMed ID: 17124092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice.
    Tersteeg C; Joly BS; Gils A; Lijnen R; Deckmyn H; Declerck PJ; Plaimauer B; Coppo P; Veyradier A; Maas C; De Meyer SF; Vanhoorelbeke K
    J Thromb Haemost; 2017 Dec; 15(12):2432-2442. PubMed ID: 28981198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradigm shift of childhood thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency.
    Yagi H; Matsumoto M; Fujimura Y
    Presse Med; 2012 Mar; 41(3 Pt 2):e137-55. PubMed ID: 22264931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic inactivation of ADAMTS13 by plasmin in human plasma: risk of thrombotic thrombocytopenic purpura.
    Shin Y; Miyake H; Togashi K; Hiratsuka R; Endou-Ohnishi K; Imamura Y
    J Biochem; 2018 May; 163(5):381-389. PubMed ID: 29228282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic thrombocytopenic purpura--then and now.
    Galbusera M; Noris M; Remuzzi G
    Semin Thromb Hemost; 2006 Mar; 32(2):81-9. PubMed ID: 16575682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms in thrombotic thrombocytopenic purpura.
    Tsai HM
    Semin Thromb Hemost; 2004 Oct; 30(5):549-57. PubMed ID: 15497097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of thrombotic thrombocytopenic purpura.
    Tsai HM
    Int J Hematol; 2010 Jan; 91(1):1-19. PubMed ID: 20058209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission.
    Di Pasquale I; Budde U; Tona F; Bertomoro A; Lombardi AM; Famoso G; Bertozzi I; Dittmer R; Schneppenheim S; Fabris F
    Thromb Res; 2019 Jan; 173():42-47. PubMed ID: 30471507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpura.
    Tsai HM
    Kidney Int Suppl; 2009 Feb; (112):S11-4. PubMed ID: 19180123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging concept of residual ADAMTS13 activity in ADAMTS13-deficient thrombotic thrombocytopenic purpura.
    Lotta LA; Wu HM; Musallam KM; Peyvandi F
    Blood Rev; 2013 Mar; 27(2):71-6. PubMed ID: 23415418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
    Schiphorst RH; van de Kar NC; van den Heuvel LP
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current concepts in thrombotic thrombocytopenic purpura.
    Tsai HM
    Annu Rev Med; 2006; 57():419-36. PubMed ID: 16409158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission.
    Lotta LA; Lombardi R; Mariani M; Lancellotti S; De Cristofaro R; Hollestelle MJ; Canciani MT; Mannucci PM; Peyvandi F
    J Thromb Haemost; 2011 Sep; 9(9):1744-51. PubMed ID: 21726405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.